Displaying 51 - 65 of 65 results
Released Company Title Industry Topic
18 Apr 2024
18:00 CEST
ONCODESIGN PRECISION MEDICINE Degroof Petercam initie la couverture d’Oncodesign Precision Medicine 20103010 Biotechnology Other subject
18 Apr 2024
18:00 CEST
ONCODESIGN PRECISION MEDICINE Degroof Petercam Initiates Coverage of Oncodesign Precision Medicine 20103010 Biotechnology Other subject
17 Apr 2024
18:00 CEST
ONCODESIGN PRECISION MEDICINE Oncodesign Precision Medicine (OPM) obtains €5.6 million in public funding for its DEMOCRITE program dedicated to the clinical development of OPM-101 20103010 Biotechnology Other subject
17 Apr 2024
18:00 CEST
ONCODESIGN PRECISION MEDICINE Oncodesign Precision Medicine (OPM) obtient un financement public de 5,6 M€ pour son programme DEMOCRITE dédié au développement clinique d’OPM-101 20103010 Biotechnology Other subject
26 Mar 2024
18:11 CET
ONCODESIGN PRECISION MEDICINE OPM annonce ses résultats annuels 2023 et fait le point sur ses développements cliniques 20103010 Biotechnology Sales
26 Mar 2024
18:11 CET
ONCODESIGN PRECISION MEDICINE OPM Publishes Its Annual Results for 2023 and Provides an Update on Its Clinical Developments 20103010 Biotechnology Sales
29 Feb 2024
18:00 CET
ONCODESIGN PRECISION MEDICINE Oncodesign Precision Medicine obtient un financement d’Aide au Développement Deep Tech pour son programme ANIMUS 20103010 Biotechnology Other subject
29 Feb 2024
18:00 CET
ONCODESIGN PRECISION MEDICINE Oncodesign Precision Medicine Obtains Deep Tech Development Funding for Its ANIMUS Program 20103010 Biotechnology Other subject
12 Feb 2024
08:00 CET
ONCODESIGN PRECISION MEDICINE Oncodesign Precision Medicine annonce le résultat de son augmentation de capital d’un montant d’environ 2 M€ 20103010 Biotechnology Other subject
25 Jan 2024
08:00 CET
ONCODESIGN PRECISION MEDICINE Oncodesign Precision Medicine receives ERDF fund totalling €2.1 M for its COMETE program 20103010 Biotechnology Other subject
25 Jan 2024
08:00 CET
ONCODESIGN PRECISION MEDICINE Oncodesign Precision Medicine lance une augmentation de capital d’environ 3 M€ avec délai de priorité pour les actionnaires 20103010 Biotechnology Share introduction and issues
25 Jan 2024
08:00 CET
ONCODESIGN PRECISION MEDICINE Oncodesign Precision Medicine obtient des subventions FEDER d’un montant total de 2,1 M€ pour son programme COMETE 20103010 Biotechnology Other subject
22 Jan 2024
18:00 CET
ONCODESIGN PRECISION MEDICINE Oncodesign Precision Medicine : Bilan semestriel du contrat de liquidité confié à la société TP ICAP (Europe) 20103010 Biotechnology Other subject
12 Dec 2023
18:00 CET
ONCODESIGN PRECISION MEDICINE TP ICAP Midcap initie à l’achat la couverture d’Oncodesign Precision Medicine 20103010 Biotechnology Other subject
12 Dec 2023
18:00 CET
ONCODESIGN PRECISION MEDICINE TP ICAP Midcap Initiates Coverage of Oncodesign Precision Medicine With a “Buy” Recommendation 20103010 Biotechnology Other subject